Coroner advises NHS England to warn prescribers about interaction of tramadol and warfarin The coroner’s report says NHS England’s response “must contain details of action taken or proposed to be taken, setting out the timetable for action” or must explain why no action is proposed.…
MHRA will take a ‘more proactive approach’ to reclassification, says chief executive June Raine told delegates at an event held on 12 December 2023 that a 5% reduction in medicine prescribing through reclassification could save the NHS £1.4bn each year.…
New valproate prescriptions must be signed off by two specialist doctors from January 2024, says MHRA The requirement for valproate prescriptions, which will come into effect on 31 January 2024, was first announced in December 2022.…
MHRA warns of dangers of fake weight loss pens after Yellow Card reports The medicines regulator said Ozempic and Saxenda pens have been confirmed as being falsified with insulin in five of the reports.…
Tirzepatide approved for weight loss treatment by regulator The Medicines and Healthcare products Regulatory Agency has said tirzepatide will be available to patients with obesity, or who are overweight, with weight-related health problems.…
Medicines regulator approves anastrozole for prevention of breast cancer in post-menopausal women NHS England says around 289,000 women at moderate or high risk of breast cancer could benefit from anastrozole.…
MHRA seizes £5m of illegally-traded medicines in 15th year of medicines crime initiative Interpol says the haul from this year's Operation Pangea posed a “significant threat to consumer safety”.…
Safety measures introduced for isotretinoin prescribing in patients aged under 18 years Recommendations to improve the safety of prescribing the acne drug isotretinoin have been made by the Commission on Human Medicines.…
UK regulator seizes 369 potentially fake weight loss pens following reports of hospitalisations The Medicines and Healthcare products Regulatory Agency said the public should consult a healthcare professional qualified to provide semaglutide and liraglutide via prescription.…
UK regulator to consider EMA recommendation to avoid topiramate in pregnancy Exclusive: The UK medicines regulator said it would carefully consider recommendations made by the European Medicines Agency, which were published following a review of data showing an increased risk of developmental disorders among children exposed to topiramate before birth.…
